Skip to content
Biodatica
Start free

Investigator

Daniel E. Goldberg

WASHINGTON UNIVERSITY · funded by NIAID

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.4M

Summed across those awards.

First award
Sep 15, 1980

Latest Jul 17, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Function of PfNCR1 at the PPM/PVM Interface

    $633k

    Jul 17, 2025NIAIDWASHINGTON UNIVERSITYNIH RePORTER · 11204185 (opens the source filing in a new tab)

  2. R21

    Mechanism of neutrophil dysfunction by Plasmodium falciparum secreted histidine-rich protein II

    $194k

    Jul 22, 2024NIAIDWASHINGTON UNIVERSITYNIH RePORTER · 11142404 (opens the source filing in a new tab)

  3. T32

    Infectious Disease/Basic Microbial Pathogenic Mechanisms

    $573k

    Sep 15, 1980NIAIDWASHINGTON UNIVERSITYNIH RePORTER · 11094778 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources